{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:33:31Z","timestamp":1774928011915,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.vaccine.2013.05.104","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T07:02:51Z","timestamp":1371106971000},"page":"3688-3694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults"],"prefix":"10.1016","volume":"31","author":[{"given":"Darius","family":"Soonawala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Verdijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alienke J.","family":"Wijmenga-Monsuur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire J.","family":"Boog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Koedam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo G.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nynke Y.","family":"Rots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.05.104_bib0005","unstructured":"Global Polio Eradication Initiative \u2013 Strategic Plan 2010\u20132012. WHO; 2010. Available from: http:\/\/www.polioeradication.org\/content\/publications\/GPEI. StrategicPlan.2010-2012.ENG. May.2010.pdf [accessed 07.08.12]."},{"key":"10.1016\/j.vaccine.2013.05.104_bib0010","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.vaccine.2009.02.071","article-title":"Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication","volume":"27","author":"Minor","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1126\/science.1115547","article-title":"Policy. OPV cessation\u2014the final step to a \u201cpolio-free\u201d world","volume":"310","author":"Aylward","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0020","unstructured":"Conclusions and recommendations of the Advisory Committee on Poliomyelitis Eradication, Geneva, November 27\u201328, 2007. Wkly Epidemiol Rec 2008;83:25\u201335."},{"key":"10.1016\/j.vaccine.2013.05.104_bib0025","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1056\/NEJMoa0909383","article-title":"Fractional doses of inactivated poliovirus vaccine in Oman","volume":"362","author":"Mohammed","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1310","article-title":"Immune surveillance in the skin: mechanisms and clinical consequences","volume":"4","author":"Kupper","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0035","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/14760584.7.8.1201","article-title":"Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice","volume":"7","author":"Nicolas","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0040","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1001\/jama.1985.03360220069031","article-title":"Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy","volume":"254","author":"Redfield","year":"1985","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.vaccine.2011.11.018","article-title":"Intradermal fractional dose inactivated polio vaccine: a review of the literature","volume":"30","author":"Nelson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0050","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1016\/j.ijid.2011.10.002","article-title":"Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines","volume":"16","author":"Cadorna-Carlos","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1086\/508427","article-title":"Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico","volume":"195","author":"Dayan","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0060","first-page":"689","article-title":"Efficacy of inactivated poliovirus vaccine in India","volume":"61","author":"Krishnan","year":"1983","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0065","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1086\/651611","article-title":"Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba","volume":"201","author":"Resik","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0070","unstructured":"Manual for the virological investigation of polio. WHO\/EPI\/GEN 97.01. WHO; 1997."},{"key":"10.1016\/j.vaccine.2013.05.104_bib0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2334-2-2","article-title":"Immunity status against poliomyelitis in Germany: determination of cut-off values in International Units","volume":"2","author":"Diedrich","year":"2002","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0080","doi-asserted-by":"crossref","unstructured":"Committee for Medicinal Products for Human Use (CHMP) guideline on the choice of the non-inferiority margin. Stat Med 2006;25:1628\u201338.","DOI":"10.1002\/sim.2584"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0085","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/00365549850161638","article-title":"IPV-Vero vaccine induces a strong booster reaction and is well tolerated in adults","volume":"30","author":"Rumke","year":"1998","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0090","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.vaccine.2005.02.013","article-title":"Combined reduced-antigen-content diphtheria\u2013tetanus\u2013acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults","volume":"23","author":"Grimprel","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0095","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jama.295.10.1152","article-title":"Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement","volume":"295","author":"Piaggio","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0100","doi-asserted-by":"crossref","first-page":"9544","DOI":"10.1016\/j.vaccine.2011.09.097","article-title":"Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector","volume":"29","author":"Simon","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0105","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1473-3099(11)70190-6","article-title":"Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6\u20139 months in Moradabad, India: a community-based, randomised controlled trial","volume":"12","author":"Estivariz","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.05.104_bib0115","doi-asserted-by":"crossref","first-page":"S444","DOI":"10.1093\/clinids\/6.Supplement_2.S444","article-title":"One-dose immunization against paralytic poliomyelitis using a noninfectious vaccine","volume":"6","author":"Salk","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.104_bib0120","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(84)90830-4","article-title":"Induction of long-term immunity to paralytic poliomyelitis by use of non-infectious vaccine","volume":"2","author":"Salk","year":"1984","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13007640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13007640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T05:50:44Z","timestamp":1539582644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13007640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":24,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0264410X13007640"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.104","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}